Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Indoco Remedies Limited ( (IN:INDOCO) ) just unveiled an announcement.
Indoco Remedies Limited has released the transcript of its Q3 FY26 earnings conference call, held on February 3, 2026, covering unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The disclosure, made to both the National Stock Exchange of India and the Bombay Stock Exchange in line with SEBI listing regulations, enhances transparency for investors by providing detailed management commentary on recent financial performance.
More about Indoco Remedies Limited
Indoco Remedies Limited is an Indian pharmaceutical company engaged in manufacturing and marketing formulations and active pharmaceutical ingredients for domestic and international markets. The company operates through multiple business segments and serves both standalone and consolidated operations, reflecting a diversified presence across key healthcare markets.
Average Trading Volume: 1,959
Technical Sentiment Signal: Sell
Current Market Cap: 19.72B INR
Learn more about INDOCO stock on TipRanks’ Stock Analysis page.